John Wolstenholme

John Wolstenholme serves as an Executive Product Associate responsible for driving product-centric procurement strategies within a federal health and medical technology environment. In this role, he bridges technical requirements with acquisition execution, ensuring that procurements align with mission-critical needs in clinical and diagnostic infrastructure. He manages the full lifecycle of complex acquisitions for medical equipment, laboratory instruments, and electromedical devices, often coordinating with clinical stakeholders to define performance specifications and evaluate vendor solutions. His work supports the agency’s broader objective of modernizing healthcare delivery through reliable, compliant, and technologically advanced procurement outcomes. While specific contractor relationships are not publicly enumerated, Wolstenholme’s procurement patterns indicate consistent engagement with manufacturers and wholesale distributors specializing in medical-grade hardware and diagnostic systems. He collaborates with a diverse base of vendors, including mid-sized manufacturers and niche suppliers with deep domain expertise in electromedical and in-vitro diagnostic technologies. His approach emphasizes technical vetting, compliance with FDA and ISO standards, and performance-based contracting to ensure product reliability and interoperability across clinical environments. Wolstenholme’s contracting activity reflects a strong preference for open competition, with 92.3% of acquisitions conducted without set-asides. However, he actively supports small business participation, with 7.7% of awards designated as Total Small Business Set-Asides under FAR 19.5. This demonstrates a balanced approach—prioritizing competition while ensuring opportunities for qualified small businesses in specialized medical manufacturing sectors. His primary procurement focus lies in NAICS 423450 (medical equipment wholesale), 334510 (electromedical apparatus manufacturing), and 334516 (analytical laboratory instruments), with additional activity in in-vitro diagnostics and fluid power components. He specializes in acquiring high-precision, regulated medical devices and diagnostic systems used in clinical, research, and hospital settings, demonstrating deep familiarity with FDA regulatory frameworks and medical device classification standards.